Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer.
Machin
D
D
Andersen
K W
KW
D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D017698:Postmenopause; D013629:Tamoxifen / Q000008:administration & dosage*; D013997:Time Factors; D016896:Treatment Outcome
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen